Chronic Kidney Disease and ESA Guidelines
41 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which condition is NOT indicated for the administration of erythropoiesis stimulating agents (ESA)?

  • Symptoms induced by anemia such as worsening heart failure
  • Anemia due to iron deficiency after eliminating other causes (correct)
  • Persistent anemia after several determinations
  • Moderate-severe anemia with Hb < 10 g/dL
  • What is the target hemoglobin range when administering ESAs?

  • 13-15 g/dL
  • 8-10 g/dL
  • 10-12 g/dL (correct)
  • 12-14 g/dL
  • What potential side effect of ESAs must be monitored during the first 6 months of treatment?

  • Hypertension (correct)
  • Abdominal pain
  • Nausea
  • Hypotension
  • Which symptom is associated with the need for ESA administration in patients with anemia?

    <p>Worsening of heart failure</p> Signup and view all the answers

    In patients who do not respond to ESA treatment, what should be screened for?

    <p>Underlying conditions like malignancy and infection</p> Signup and view all the answers

    What is the eGFR range that classifies Stage 2 chronic kidney disease?

    <p>60–89 mL/min/1.73 m2</p> Signup and view all the answers

    Which of the following is NOT an indication for hemodialysis in end-stage kidney disease?

    <p>Hyperkalemia that is correctable with medication</p> Signup and view all the answers

    In chronic kidney disease, what is the glomerular filtration rate (GFR) threshold indicating end-stage kidney disease (ESKD)?

    <p>&lt;10–15 mL/min/1.73 m2</p> Signup and view all the answers

    What might be a symptom associated with advanced chronic kidney disease?

    <p>Loss of appetite</p> Signup and view all the answers

    What is the significance of A3 in the context of chronic kidney disease classification?

    <p>It represents a protein excretion of &gt;300 mg/g.</p> Signup and view all the answers

    What type of dialysis is performed when patients cannot maintain homeostasis through diet or medications?

    <p>Hemodialysis</p> Signup and view all the answers

    Which option lists a consequence of severe chronic kidney disease?

    <p>Electrolyte imbalance</p> Signup and view all the answers

    What is the primary process that allows solutes to move across the membrane in a solvent?

    <p>Ultrafiltration</p> Signup and view all the answers

    Which analogy best describes the process of convection as related to solute movement?

    <p>An ocean wave pushing sea shells onto the shore</p> Signup and view all the answers

    What determines the movement of solvent in the process of ultrafiltration?

    <p>Pressure gradients across the membrane</p> Signup and view all the answers

    What happens to molecules in ultrafiltration once equilibrium is achieved?

    <p>They continue to move but at a slower rate</p> Signup and view all the answers

    In the context of dialysis, what is the role of the dialysate?

    <p>To provide a medium for solute exchange</p> Signup and view all the answers

    How is the direction of blood flow related to dialysate flow in ultrafiltration?

    <p>They flow in opposite directions</p> Signup and view all the answers

    What type of molecules are primarily exchanged between the blood and the dialysate during ultrafiltration?

    <p>Small molecules</p> Signup and view all the answers

    What is a key factor that affects the efficiency of ultrafiltration?

    <p>Surface area of the membrane</p> Signup and view all the answers

    What is the primary purpose of achieving equilibrium in the context of molecule movement?

    <p>To ensure balanced solute levels across the membrane</p> Signup and view all the answers

    What primary condition is linked to an increased risk of renal injury?

    <p>Diabetes</p> Signup and view all the answers

    What is the recommended HbA1c target for diabetes patients to minimize renal complications?

    <p>7%</p> Signup and view all the answers

    Which process is primarily responsible for the deterioration of renal function in chronic tubulointerstitial nephritis?

    <p>Tubulointerstitial fibrosis</p> Signup and view all the answers

    What percentage of end-stage renal disease cases is attributed to primary chronic tubulointerstitial nephritis?

    <p>10% to 20%</p> Signup and view all the answers

    What is a common characteristic of both acute and chronic renal injuries?

    <p>Overlapping causes</p> Signup and view all the answers

    Which substance is NOT commonly associated with renal toxicity?

    <p>Vitamin D</p> Signup and view all the answers

    What approach has been shown to improve both macro and microvascular complications related to diabetes?

    <p>Intensive glycaemic control</p> Signup and view all the answers

    Which of the following is NOT considered a risk factor for chronic tubulointerstitial nephritis?

    <p>Infection</p> Signup and view all the answers

    Which of the following conditions is associated with hypoglycemia in CKD patients?

    <p>Chronic renal failure</p> Signup and view all the answers

    What type of renal injury often takes a more indolent course compared to acute injuries?

    <p>Chronic tubulointerstitial nephritis</p> Signup and view all the answers

    What is the preferred diuretic when the eGFR is less than 30 ml/min?

    <p>Loop diuretics</p> Signup and view all the answers

    Which diuretic is considered more metabolically neutral and preferred over thiazides?

    <p>Indapamide</p> Signup and view all the answers

    Primary CTIN accounts for what percentage of end-stage renal disease cases worldwide?

    <p>10% to 20%</p> Signup and view all the answers

    When is the combination of loop diuretics and thiazides indicated?

    <p>When resistance to loop diuretics occurs</p> Signup and view all the answers

    Which condition characterizes a milder renal injury that progresses slowly?

    <p>Chronic tubulointerstitial nephritis</p> Signup and view all the answers

    What treatment is indicated as a second line after ACEI/ARB when GFR is greater than 30 ml/min?

    <p>Thiazide diuretics</p> Signup and view all the answers

    In cases of resistance to loop diuretics, when should their action be potentiated with thiazides?

    <p>eGFR &gt; 15 ml/min</p> Signup and view all the answers

    Which of the following substances is indicated for chronic conditions alongside thiazide use?

    <p>ACE inhibitors</p> Signup and view all the answers

    What factor contributes to the growing number of cases of ESRD globally?

    <p>Increased identification of causes</p> Signup and view all the answers

    Which condition may arise as either a primary or secondary phenomenon?

    <p>Chronic tubulointerstitial nephritis</p> Signup and view all the answers

    Study Notes

    Lecture 6: Chronic Kidney Disease (CKD)

    • CKD is defined as abnormalities of kidney structure or function, persisting for more than 3 months and affecting patient health.
    • The abnormalities stem from progressive and irreversible destruction of nephrons.
    • Learning objectives include identifying CKD patients, differentiating etiologies, and managing complications.

    Definition of CKD

    • Abnormalities in kidney structure or function persisting for more than 3 months.
    • Influence patient health status
    • Complex clinical and biological manifestations due to nephron destruction.
    • Temporal criteria: > 3 months
    • Functional criteria: eGFR < 60 ml/min/1.73m2
    • Structural criteria: Kidney damage

    End-Stage Kidney Disease (ESKD)

    • Late stage of chronic renal failure
    • Without replacement treatment of renal function or renal transplantation, survival is impossible.
    • Glomerular filtration rate (GFR) is below 15 ml/min.

    Indicators of Kidney Damage

    • Albuminuria > 30 mg/day (proteinuria > 150 mg/day)
    • Urinary sediment abnormalities (red blood cells, red blood cell casts)
    • Electrolyte, acid-base, and metabolic anomalies due to renal tubular dysfunction.
    • Histological kidney lesions (kidney biopsy)
    • Structural kidney lesions detected by imaging examinations (morphological asymmetry, hyperechogenicity, nephrocalcinosis, contour irregularities, cystic diseases, hydronephrosis)
    • History of kidney transplantation

    Conditions Associated with Increased CKD Risk

    • Diabetes
    • Hypertension
    • Cardiovascular diseases
    • Systemic diseases affecting the kidney (e.g., systemic lupus erythematosus)
    • Structural kidney diseases (lithiasis, prostate hypertrophy)
    • Weight under 2.5 kg at birth
    • First-degree relatives with renal replacement treatment or hereditary kidney diseases
    • Chronic exposure to nephrotoxic drugs (NSAIDs)

    Prevalence of CKD

    • Global prevalence is consistently estimated at 11% to 15%.
    • Most cases are at stage 3.
    • At least 1 in 10 people suffer from CKD.
    • Main causes: diabetes and hypertension.

    Incidence of CKD

    • Incidence varies by ethnicity.
    • CKD is 3-4 times more common in people of Black African descent in the UK and the USA.
    • Hypertensive nephropathy is a prevalent cause of ESKD in this group.
    • Prevalence is higher in some Asian groups than in white people.

    Staging of CKD

    • Prognosis of CKD depends on GFR and albuminuria category.
    • Details on various stages are provided in the text.

    Documentation of Chronic Anomalies

    • Dynamic analysis of anomalies (from the patient's history or repeat testing every 3 months) is essential for diagnosis.

    Complete CKD Diagnosis

    • Includes primary kidney disease and the degree of risk of CKD.
    • Indicates eGFR (G) and albuminuria (A) categories.
    • Reflects that both parameters correlate with progressive renal impairment and cardiovascular risk.
    • Example: CKD chronic glomerulonephritis - with risk that G3aA3.
    • Stage 3 CKD is divided in stages 3a and 3b to recognize increased cardiovascular complications with more advanced disease.
    • Patients with G2 stage CKD may not show disease unless other damage is present (haematuria, proteinuria, structurally abnormal kidneys, inherited kidney disease or biopsy changes consistent with kidney disease).

    Etiology of CKD

    • Detailed list of causative factors grouped by disease type.

    Screening of CKD

    • Methods for detecting CKD (albuminuria, urine dipstick, GFR estimation using serum creatinine).

    eGFR Recommendations

    • eGFR is a crucial indicator of renal function.
    • Value is expressed as a percentage of residual renal function.
    • Epidemiological studies link low eGFR (<60ml/min) with increased risk of adverse renal outcomes, requiring renal replacement therapy, and cardiovascular morbidity and mortality.

    Progression of CKD

    • Rate of renal function decline depends on underlying nephropathy, albuminuria, eGFR at diagnosis, and blood pressure control.
    • Chronic glomerular diseases tend to deteriorate faster than chronic tubulo-interstitial nephropathies.

    Causes of Accelerated CKD Progression

    • Uncontrolled hypertension
    • Proteinuria over 0.5g/g
    • Cardiovascular disease (heart failure)
    • Uncontrolled blood sugar (diabetes)
    • Untreated urinary tract obstruction
    • Reactivation of primary kidney disease
    • Dyslipidemia
    • Obesity
    • Smoking
    • NSAIDs use

    Prognosis of CKD

    • Correlates with hypertension (especially poorly controlled), proteinuria, and the degree of interstitial scarring on histology.
    • Treatment aims to inhibit the effect of angiotensin II and reduce proteinuria using ACEIs and ARBs to help nephroprotection.

    Management of CKD

    • General measures (diet, body mass control, physical activity, avoiding self-medication, such as NSAIDs).
    • Renoprotection (Controlling blood pressure and proteinuria)
    • Specific measures for the treatment of causative nephropathy (intensive glycaemic control, immunosuppressive treatment, use of vasopressin V2 receptor antagonists)
    • Other measures to limit progression, including controlling dyslipidemia with statins.

    Management of CKD-MBD

    • Reduction of phosphate and limiting the calcium load (dietary restriction and use of gut phosphate binders)
    • Control of PTH with calcitriol vitamin D analogues or calcimimetics.

    Cardiovascular Disease in CKD

    • Cardiovascular risk is much higher in CKD compared to the general population.
    • Risk factors include hypertension, diabetes mellitus, dyslipidemia, smoking, and male gender.
    • Conditions like left ventricular hypertrophy and diastolic and systolic dysfunction are common.
    • Pericarditis may also occur in CKD stage G5.

    Skin Disease in CKD

    • Pruritus (itching) is common due to accumulating waste products.
    • Nephrogenic systemic fibrosis (NSF) is a fibrosing skin disorder affected by patients with a GFR < 30ml/min and/or undergoing RRT.
    • Caciphylaxis (calcific uraemic arteriolopathy) is a rare, life-threatening condition.
    • Prevention measures are crucial for managing these complications.

    Gastrointestinal Pathologies in CKD

    • Uremia halena, nausea, vomiting, intestinal dysmicrobism, gastrointestinal bleeding, and acute pancreatitis are potential complications.

    Metabolic Abnormalities in CKD

    • Insulin catabolism is altered.
    • Renal glucose production is diminished or altered, which impacts insulin requirements in diabetic patients.
    • Insulin resistance and impaired glucose tolerance frequently accompany advanced CKD.
    • Lipid metabolism is disrupted, leading to impaired clearance of triglyceride particles and hypercholesterolemia, especially in advanced CKD.
    • Gout risk increases due to urate retention as GFR declines.
    • Multiple other metabolic complications are detailed.

    Nervous System Abnormalities in CKD

    • Uremia alters the central nervous system.
    • Increased circulating catecholamines cause downregulation of a-receptors and impair baroreceptor sensitivity, and affect the autonomic nervous system.
    • Median nerve compression in the carpal tunnel and symmetrical polyneuropathy are common consequences.

    Correction of Specific Complications

    • Includes management of hyperkalemia (using insulin, glucose, sodium bicarbonate, sodium salts of specific anions), acidosis (using bicarbonate), and more.

    Precautions in Drug Administration

    • Precautions are needed for ACE/ARBs, beta-blockers, statins, NSAIDs, and more because of specific risk factors and renal function.

    Renal Replacement Therapy (RRT)

    • Initiation is based on the presence of complications associated with decreased GFR (including hyperkalemia, severe metabolic acidosis, severe hyperhydration, uremic pericarditis, signs of uremic intoxication, and persistent GFR below 6-8 ml/min).

    Detailed information for each subject can be extrapolated from the OCR text provided.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Nephrology Lecture 6 PDF

    Description

    This quiz explores critical concepts related to erythropoiesis stimulating agents (ESAs) and chronic kidney disease (CKD). Test your knowledge on indications for ESA administration, target hemoglobin ranges, and important monitoring aspects during treatment. Additionally, you'll assess your understanding of kidney function and hemodialysis criteria.

    More Like This

    Use Quizgecko on...
    Browser
    Browser